The story appears on

Page A2

March 5, 2021

GET this page in PDF

Free for subscribers

View shopping cart

Related News

Home » Metro

Over 100 delegates from city in Beijing to attend the session

MORE than 100 members of the National Committee of the Chinese People’s Political Consultative Conference from Shanghai are attending the annual plenary session of China’s top political advisory body that opened yesterday, the CPPCC Shanghai Committee said.

So far, 171 proposals have been submitted from these political advisers in advance, along with the text of 10 conference speeches and 18 articles about society’s condition and people’s opinions. These proposals focus on many topics including elder care and nursing, health care, education and information security.

Tan Jianfeng, a national CPPCC member from Shanghai, keeps an eye on data safety. In his three proposals, he seeks the creation of a national “data bank” for better regulation of key data, a review system on the management and use of data and enhancing supervision of data security related to smart cars.

According to Tan, among the massive amounts of data, some are unique and non-renewable. He cited personal biological characteristics like faces, fingerprints, DNA and people’s medical records. If these data are stolen, they cannot be retrieved or changed, which could be seen as a huge and irreversible risk to people’s privacy.

He suggests setting up of a national data bank to allow professional institutions to manage and control such data and prevent them from being collected by enterprises at will.

“A few companies make profits by selling data they collect, and that’s illegal,” Tan said.

“So the country should have clear guidelines on who can use the data and how that information can be used, as well as how data can be shared and destroyed.”

Zhou Hanmin, who is also the vice chairman of the Central Committee of the China National Democratic Construction Association, proposes facilitating the development of medicine for rare diseases that affect a small percentage of the population. Because few pharmaceutical companies make drugs for rare diseases, they’re sometimes referred to as “orphan drugs.”




 

Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.

沪公网安备 31010602000204号

Email this to your friend